Effect of Ledipasvir and Sofosbuvir on Proteinuria and Estimated Glomerular Filtration Rate in Patients With Early Stage (1-3) Hepatitis C Associated Chronic Kidney Disease
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Jan 2018
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 27 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 04 Oct 2017 Planned End Date changed from 1 Apr 2018 to 1 Dec 2019.
- 04 Oct 2017 Planned primary completion date changed from 31 Dec 2017 to 31 Dec 2018.